The transgenic construct contains a bidirectional CMV promoter with a tetracycline operator (tetO) site, pBiGNot1, directing expression of a b-galactosidase (lacZ) reporter followed by a b-globin polyA signal on one side and human ATP2B4 cDNA squence on the other side. (J:128144)